Gastric cancer is the fifth most common cancer, yet research and prevention efforts remain limited. Lorna Rothery spoke with Dr Jin Young Park, the leader of the Gastric Cancer Prevention Team at the International Agency for Research on Cancer, about the necessary steps for improvement.
Young people with cancer are potentially being robbed of the ability to have children as important information around fertility is not being communicated at the earliest opportunity says the cancer charity, Teenage Cancer Trust.
In this exclusive interview with Prof Olufunmilayo Lesi, Regional Medical Officer for Viral Hepatitis from the World Health Organization (WHO) Office for the Africa Region, discusses tackling viral hepatitis in Africa.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Here, Haruki Komatsu discusses how Paediatric Hepatitis B virus (HBV) infection is one of the main things which can lead to liver cirrhosis and hepatocellular carcinoma.
Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
